Nikica Mirošević Skvrce

Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study

Nikica Mirošević Skvrce, Viola Macolić Šarinić, Iva Mucalo et al. · Croatian Medical Journal · 2011 · 58 citations · Full text

<i>ABCG2</i> Gene Polymorphisms as Risk Factors for Atorvastatin Adverse Reactions: A Case–Control Study

Nikica Mirošević Skvrce, Viola Macolić Šarinić, Iveta Šimić et al. · Pharmacogenomics · 2015 · 36 citations

<i>CYP2C9</i> and <i>ABCG2</i> Polymorphisms as Risk Factors for Developing Adverse Drug Reactions in Renal Transplant Patients Taking Fluvastatin: A Case–Control Study

Nikica Mirošević Skvrce, Nada Božina, Lada Zibar et al. · Pharmacogenomics · 2013 · 31 citations

Genetic polymorphisms of cytochrome P450 enzymes: <i>CYP2C9</i> , <i>CYP2C19</i> , <i>CYP2D6</i> , <i>CYP3A4</i> , and <i>CYP3A5</i> in the Croatian population

Lana Ganoci, Tamara Božina, Nikica Mirošević Skvrce et al. · Drug Metabolism and Personalized Therapy · 2017 · 31 citations

Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose

Monika Raethke, Florence van Hunsel, Nicolas H. Thurin et al. · Drug Safety · 2023 · 26 citations · Full text

Vaccination, Vaccine Safety, Preventive Medicine +12